ArticleFrontiers in pharmacology2022

BRAF L485-P490 deletion mutant metastatic melanoma sensitive to BRAF and MEK inhibition: A case report and literature review.

Simeng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.